Drug Shortage Report for TEVA-FLUOXETINE
| Report ID | 153721 |
| Drug Identification Number | 02216590 |
| Brand name | TEVA-FLUOXETINE |
| Common or Proper name | TEVA-FLUOXETINE 20MG CAPSULES |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUOXETINE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-01-27 |
| Estimated end date | |
| Actual end date | 2024-05-09 |
| Shortage status | Resolved |
| Updated date | 2024-05-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.